Company Profile

Jubilant Biosys Ltd., is a part of the Jubilant Life Sciences family of companies with R&D centers in India and business offices in Asia and North America.

Jubilant Biosys has global reach and provides comprehensive drug discovery and Contract research services – from target discovery to candidate selection in partnership with leading healthcare companies worldwide.

About Jubilant Biosys, India

With a clear scientific focus in Oncology, Metabolic Disorders, Central Nervous System (CNS) diseases, Pain and Inflammation, Jubilant Biosys has rapidly emerged as a leading collaborator for pharmaceutical and biotechnology companies worldwide. In each of these therapeutic areas, Jubilant Biosys has developed a deep level of expertise in discovery informatics, computational chemistry, medicinal chemistry, structural biology, biology, in vivo, in vitro models and translational sciences. Combined with strong clinical development and manufacturing capabilities from other Jubilant subsidiaries, Jubilant Biosys has emerged as fully integrated company with end-to-end solutions.

Our ability to be the preferred collaborator in the Drug Discovery domain is sustained by our commitment to comply with and continually improve our Quality Systems and to provide the following Services:

  • Contract Research
  • Pre-clinical CRO
  • Drug Discovery
  • Virtual Screening
  • Protein Crystallization
  • Toxicology
  • In Vitro ADME
  • Medicinal Chemistry

Jubilant Biosys collaborates with the world’s leading pharmaceutical, biotech companies, academic Institutions and research foundations.

Innovative and rigorous science, excellence in execution, and absolute integrity combined with flexible business models has enabled Jubilant Biosys to deliver valuable outcomes in a relatively short period of time. The hallmark of Jubilant Biosys’s collaborative model is the creation of value to their partners.

Jubilant Advantage

  • Target identification to proof of concept
  • Largest pool of drug discovery talent in India
  • Diverse discovery technologies
  • Creative partnering / collaboration models
  • Experienced portfolio management capabilities